| Literature DB >> 23167478 |
R Bacigalupo1, P Cudd, C Littlewood, P Bissell, M S Hawley, H Buckley Woods.
Abstract
Obesity is a global epidemic with major healthcare implications and costs. Mobile technologies are potential interventions to promote weight loss. An early systematic review of this rapidly growing area of research was conducted. Electronic databases were searched for articles published between January 1998 and October 2011. Data sources included Medline, Embase and the Cochrane Central Register of Controlled Trials. Ongoing research was searched for using clinical trials databases and registers. Out of 174 articles retrieved, 21 met the inclusion criteria of randomized controlled trials (RCTs) on mobile technology interventions facilitating weight loss in overweight and obese adults with any other comparator. A narrative synthesis was undertaken. Seven articles were included and appraised using the Cochrane risk of bias tool: four presented a low risk of bias and three presented a high risk of bias. There is consistent strong evidence across the included multiple high-quality RCTs that weight loss occurs in the short-term because of mobile technology interventions, with moderate evidence for the medium-term. Recommendations for improving the reporting and quality of future trials are made including reporting weight loss in percent to meet clinical standards, and including features such as long-term follow-up, cost-effectiveness and patient acceptability.Entities:
Keywords: mobile technology; obesity; overweight; weight loss
Mesh:
Year: 2012 PMID: 23167478 PMCID: PMC3618375 DOI: 10.1111/obr.12006
Source DB: PubMed Journal: Obes Rev ISSN: 1467-7881 Impact factor: 9.213
Medline example literature search strategy
| Search | Keywords |
|---|---|
| 1. | (Mobile technology or m-health or mhealth or personal digital assistants or PDA* or mobile phone* or hand-held computers or pocket computers or PalmPilots or assistive technology or telecare or telehealth or telemonitoring).ti,ab (9,536). |
| 2. | telemedicine/ (7,995) |
| 3. | 1 or 2 (16,291) |
| 4. | (obesity or weight management or BMI).ti,ab (124,779). |
| 5. | weight loss/ or obesity/ (107,873) |
| 6. | 4 or 5 (171,008) |
| 7. | 3 and 6 (126) |
| 8. | Clinical trial/ (460,598) |
| 9. | Randomized controlled trial/ (301,753) |
| 10. | Randomization/ (70,565) |
| 11. | Single blind procedure/ (0) |
| 12. | Double blind procedure/ (0) |
| 13. | Crossover procedure/ (0) |
| 14. | Placebo/ (0) |
| 15. | Randomi?ed controlled trial$.tw (49,269). |
| 16. | Rct.tw (4,856). |
| 17. | Random allocation.tw (899). |
| 18. | Randomly allocated.tw (12,902). |
| 19. | Allocated randomly.tw (1,518). |
| 20. | (allocated adj2 random).tw (673). |
| 21. | Single blind$.tw (8,976). |
| 22. | Double blind$.tw (98,254). |
| 23. | ([treble or triple] adj blind$).tw (219). |
| 24. | Placebo$.tw (130,532). |
| 25. | Prospective study/ (290,434) |
| 26. | or/8–25 (879,782) |
| 27. | Case study/ (1,506,736) |
| 28. | Case report.tw (164,891). |
| 29. | Abstract report/ or letter/ (723,199) |
| 30. | or/27–29 (2,103,244) |
| 31. | 26 not 30 (857,094) |
| 32. | 7 and 31 (24) |
| 33. | limit 32 to yr = ‘1998-Current’ (24) |
Inclusion/exclusion criteria
| Population | Overweight, obese/morbidly obese (body mass index > 25) human adults (age > or = to 18) |
|---|---|
| Intervention | Mobile technologies excluding only Internet desktop/laptop computers |
| Comparators | Any other comparator including no treatment/treatment as usual |
| Outcomes | Primary outcome: weight loss however measured. Secondary outcomes: body mass index, waist circumference, weight maintenance, quality of life/satisfaction with technology |
| Study design | Randomized controlled trial |
Figure 1Literature search results.
Study characteristics and main results
| Reference | |||||||
|---|---|---|---|---|---|---|---|
| Country | USA | Finland | United Kingdom | Germany | USA | Germany | USA |
| Experimental group | Text pager Diet and physical activity Self and monthly weigh-ins. + lottery chance OR deposit fined Participants financially incentivized | Mobile phone Diet Self and 3 monthly independent monitoring | Mobile phone and accelerometer Physical activity Self-monitoring and peer support Participants paid | Telemonitoring (weighing scales and accelerometer) Diet and physical activity Self and semi independent daily, weekly feedback, monthly blood samples, monitoring Participants charged | Mobile phone Diet and physical activity Self and monthly weigh-ins. + deposit fined – either 24 or 32 weeks weight loss Participants paid and fined | Telemonitoring (weighing scales and accelerometer) Diet and physical activity Self and weekly independent monitoring; family participation One sub-group received financial incentive | Mobile phone Diet and physical activity Self, weekly and monthly independent monitoring |
| Comparison | No access to technology, just monthly weigh-ins. Same information as EG | No access to technology and service Less information than EG | Access to accelerometer technology Less information than EG Participants paid | No access to technology and service Less information than EG | No use of mobile phone Same information as EG | No access to technology and service Same information as EG | No access to technology and service Less information than EG |
| Subjects | N = 57 (F5%, M95%) N = 19 Intervention N = 19 each Control Age 30–70 years (mean = NS) BMI 30–40 kg/m2 (mean = 34.9) | N = 125 (F78%, M22%) N = 62/42 Intervention N = 63/40 Control Age 25–44 years (mean = 38.1) BMI 25–36 kg/m2 (mean = 30.6) | N = 77 (F66%, M34%) N = 47 Intervention N = 30 Control Age 30–55 years (mean = 40.4) BMI 19–30 kg/m2 (mean = 26.3) | N = 70 (F51.5%, M48.5%) N = 35 Intervention N-35 Control Age 48–66 years (mean 57.5 ) BMI 28.9–41 kg/m2 (mean ) | N = 66 (F17%, M83%) N = 22 Intervention N = 22 each Control Age 30–70 years (mean = NS) BMI 30–40 kg/m2 (mean = 34.6) | N = 111 adults (F64%, M36%) N = 18 Intervention N = 93 Control Age 20–60 years | N = 78 (F80%, M20%) N = 39 Intervention N = 39 Control Age 25–55 years (mean = 44.9) BMI 25–39.9 kg/m2 (mean = 33.2) |
| Trial length | 16 weeks | 52 weeks | 9 weeks | 26 weeks | 24/32 weeks | 26 weeks | 16 weeks |
| Targets | 0.45 kg per week adjusted at weigh-ins | Chosen by participants | Chosen by participants | Calorific reduction and exercise prescribed | 0.45 kg per week adjusted at weigh-ins | Calorific reduction and exercise prescribed | Calorific reduction prescribed; method chosen by participants |
| Weight loss | EG1 (Deposit contract) 6.3 kg (95% CI, | EG 5.4% (SD 5.8) 4.5 kg (SD 5.0) CG 1.3% (SD 6.5) 1.1 kg (SD 5.8) Difference 4.1% greater for EG (SD 1.4%) (for a 95% CI quoted as | EG −11.3 plus or minus 5.9 (relative %) −11.8 plus or minus 7.6 (absolute) CG −0.2 plus or minus 2.9% (relative%) −0.3 plus or minus 2.9 (absolute) Difference NS | EG 3.91 kg, 6.54 (SD) CG 0.53 kg, 6.21 (SD) Difference NS (95% CI, 0.56, 14.50, | EG 8% CG 4.8% Difference 3.7% greater for EG | EG 3.16% CG 1.01% Difference 1.97 kg greater for EG (95% CI = 0.34 to 3.6 kg, | |
| BMI change | EG −0.24, SE = 0.11 CG +0.10, SE = 0.14 (95% CI = −0.02 to 0.70, | EG −11.3 plus or minus 5.9 (relative %) −4.1 plus or minus 2.6 (absolute) CG −0.2 plus or minus 2.9 (relative %) −0.1 plus or minus 1.0 (absolute) |
This study comprised four different dyads of control and experimental groups where the only difference between control and corresponding experimental group was use of telemedicine.
Estimates from data supplied about recruits, i.e. not provided explicitly nor as an inclusion/exclusion criteria.
This value is quoted in the paper but seems is a typo as the difference of published values would be 3.2%.
BMI, body mass index; CG, control group; CI, confidence interval; EG, experimental group; NS, not significant; SD, standard deviation; SE, standard error.
Study features
| Study feature | |||||||
|---|---|---|---|---|---|---|---|
| Self-monitoring | Weight | Weight | Exercise | Weight and exercise | Weight | Weight and exercise | Weight |
| Participants asked to report weight frequently | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ |
| Technology automatically records physical activity | X | X | ✓ | ✓ | X | ✓ | X |
| Counsellor feedback and communication | Daily | No, but auto SMS | No, but auto SMS/e-mail | Weekly by letter | Daily | Weekly by letter, and auto online | Monthly by phone, and auto SMS/mms |
| Automatic feedback given | Responsive | Responsive | Responsive | X | Responsive | Responsive | 2–5 a day |
| Human professional feedback given | X | X | X | weekly | X | weekly | monthly |
| Social support | No | No | Yes | No | No | Not explicit, but family likely | No, though checked if it was happening |
| Opportunity for peer support | X | X | ✓ | X | X | X | X |
| Structured programme | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Individually tailored | X | ✓ | ✓ | ✓ | X | ✓ | ✓ |
| Goal includes to reduce calorie intake | X | ✓ | X | ✓ | X | ✓ | ✓ |
| Weight loss goal set by participants | X | ✓ | ✓ | X | X | X | X |
| Otherwise explicitly healthy recruits | X | ✓ | ✓ | X | X | X | X |
| Any blinding measures reported | X | ✓ | X | X | X | X | X |
| Intervention duration | 16 weeks | 12 months | 9 weeks | 6 months | 32 weeks | 6 months | 4 months |
| All participants receive same advice (re diet and/or exercise) | ✓ | X | X | X | ✓ | ✓ | X |
| In addition to ‘by interview’ baselines behaviours established over | – | – | 3 weeks (activity) | – | – | 3 d (diet) | – |
| Participants record on paper | X | X | X | X | X | X | ✓ |
| Internet key element of intervention | X | ✓ | ✓ | ✓ | X | X | ✓ |
| Comparator without technology | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ |
| Mid-study independent weight checks | ✓ | ✓ | X | Automatic | ✓ | Automatic | ✓ |
| Post weight loss follow-up | ✓ | X | X | X | ✓ | X | X |
As relevant to experimental group.
To pass data electronically daily.
Daily measures on bluetooth scales, but could be cheated.
SMS, short message service.
Completed risk of bias tool
| Was the method of randomization adequate? | Was the treatment allocation concealed? | Was the patient blinded to the intervention? | Was the care giver blinded to the intervention? | Was the outcome assessor blinded to the intervention? | Was the dropout rate described and acceptable? | Were all randomized participants analysed in the group to which they were allocated? | Free of selective reporting? | Similarity of baseline characteristics? | Co-interventions avoided or similar? | Compliance acceptable? | Timing of outcome assessments similar? | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haapala | ? | ? | ? | ✓ | ? | – | ✓ | ✓ | ✓ | – | ✓ | ✓ | 6 |
| Hurling | – | ? | – | – | – | ✓ | ✓ | ✓ | ✓ | ? | ✓ | ✓ | 6 |
| Luley | ? | ? | – | ? | – | – | ✓ | ✓ | – | ? | ✓ | ✓ | 4 |
| Patrick | ✓ | ? | – | – | ? | – | ✓ | ✓ | – | ? | ✓ | ✓ | 5 |
| Luley | ✓ | ? | – | – | – | ✓ | ✓ | ✓ | ✓ | ? | ? | ✓ | 6 |
| John | ? | ? | ? | ? | ? | ✓ | ✓ | ✓ | ✓ | ? | ? | ✓ | 5 |
| Volpp | ✓ | ✓ | – | – | – | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9 |
✓, yes; –, no; ?, unclear.